SMPD1 and neoplasm: ASMase knockout (ASMase−/−) and wild-type (WT) mice bearing fibrosarcoma (MCA/129 tumour line) were treated with 10 Gy or 20 Gy in five fractions alongside or independently of USMB treatments.